Big data on efficacy and toxicity levels for ibrutinib in CLL
What should we be focusing on in CLL research?
ASH highlights in CLL and lymphoma by Dr Andrew Zelenetz
The Cassiopeia trial - assessing daratumumab in the context of stem cell transplantation
Ibrutinib and ublituximab – a promising combination regimen for treating CLL?